FDA Accepts Application for Botox to Treat Masseter Muscle Prominence
If approved, the neurotoxin would be the first indicated for the temporary improvement of marked to very marked masseter muscle prominence in the United States.
If approved, the neurotoxin would be the first indicated for the temporary improvement of marked to very marked masseter muscle prominence in the United States.
The company is building a dedicated sales and medical affairs team to drive adoption of its neurotoxin and provide practices with direct clinical and commercial support.
The minimally invasive system uses real-time dual thermal monitoring and cannula-delivered energy to support skin firmness across the face and body.